Jakap Koo bought $57k of APUS
director at Apimeds Pharmaceuticals US, Inc.. 28,500 shares at an average of $1.99, traded May 12, 2025, filed May 14, 2025.
Score components
- +15RoleDirector
- +7Trade size$57k at market
- 0Relative to holdingsHoldings up 4.6%
- 0Price contextNo price history yet
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -1.6%, 3m -12.9%, 6m +44.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001474506-25-000090, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 12, 2025 | POpen-market purchase Common Stock, par value $0.01 per share | +28,500 | $1.99 | $57k | 643,885 | May 14, 2025 |
Related signals
Other insiders at Apimeds Pharmaceuticals US, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | Apimeds Pharmaceuticals US, Inc. | Christopher Kim Chairman and CMO | $50k 27,500 shares | - | |
| 53Moderate | Apimeds Pharmaceuticals US, Inc. | Inscobee Inc. owner | $2.0M 500,000 shares | +34% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.